Literature DB >> 4879372

Cyclophosphamide in the treatment of ovarian cancer.

D G Decker, E Mussey, G D Malkasian, C E Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4879372     DOI： 10.1097/00003081-196806000-00001

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy in the management of ovarian carcinoma: a review.

Authors:  J S Malpas
Journal:  J R Soc Med       Date:  1979-05       Impact factor: 5.344

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

3.  In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.

Authors:  M J Xu; D S Alberts; R Liu; A Leibovitz; Y Liu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia.

Authors:  Yitang Li; Yonghui Jia; Muriel Pichavant; Fabien Loison; Bara Sarraj; Anongnard Kasorn; Jian You; Bryanne E Robson; Dale T Umetsu; Joseph P Mizgerd; Keqiang Ye; Hongbo R Luo
Journal:  Blood       Date:  2009-03-13       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.